DOI: 10.2337/diacare.29.03.06.dc05-1764 © 2006 by the American Diabetes Association
The 10-s Maximal SprintA novel approach to counter an exercise-mediated fall in glycemia in individuals with type 1 diabetes
1 School of Human Movement and Exercise Science, University of Western Australia, Crawley, Australia Address correspondence reprint requests to Vanessa A Bussau, BSc (Hons), School of Human MovementExercise Science, University of Western Australia, 35 Stirling Hwy., Crawley, Western Australia, Australia, 6009. E-mail: vbussau{at}cyllene.uwa.edu.au OBJECTIVETo investigate whether a short maximal sprint can provide another means to counter the rapid fall in glycemia associated with moderate-intensity exercise in individuals with type 1 diabetes and therefore decrease the risk of early postexercise hypoglycemia.
RESEARCH DESIGN AND METHODSIn the study, seven male subjects with type 1 diabetes injected their normal insulin dose and ate their usual breakfast. When their postprandial glycemia fell to RESULTSModerate-intensity exercise resulted in a significant fall (P < 0.05) in glycemia in both trials (means ± SE: 3.6 ± 0.5 vs. 3.1 ± 0.5 mmol/l for sprint and control, respectively). The subsequent short cycling sprint opposed a further fall in glycemia for 120 min, whereas in the absence of a sprint, glycemia decreased further (3.6 ± 1.22 mmol/l; P < 0.05) after exercise. The stabilization of glycemia in the sprint trial was associated with elevated levels of catecholamines, growth hormone, and cortisol. In contrast, these hormones remained at stable or near-stable levels in the control trial. Changes in insulin and free fatty acid levels were similar in the sprint and control trials. CONCLUSIONSThese results suggest that after moderate-intensity exercise, it is preferable for young individuals with insulin-treated, complication-free type 1 diabetes to engage in a 10-s maximal sprint to acutely oppose a further fall in glycemia than to only rest. The addition of the sprint after moderate-intensity exercise provides another means to reduce the risk of hypoglycemia in active individuals with type 1 diabetes.
This article has been cited by other articles:
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||